Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens
- 1 January 1992
- journal article
- critical commentary
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 20 (1) , 42-47
- https://doi.org/10.1002/mpo.2950200109
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hypophosphataemic rickets after ifosfamide treatment in children.BMJ, 1989
- Ifosfamide-induced renal tubular defectsCancer, 1989
- Nephrotoxicity associated with ifosfamideEuropean Journal of Pediatrics, 1988
- Ifosfamide — Dosing and SchedulingPublished by S. Karger AG ,1987
- Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.Journal of Clinical Oncology, 1986
- Ifosfamide-pharmacology, safety and therapeutic potentialCancer Treatment Reviews, 1985
- Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Ifosfamide and vincristine in paediatric tumours. A phase II studyEuropean Paediatric Haematology and Oncology, 1984
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)European Journal of Cancer and Clinical Oncology, 1982
- Experimentelle und klinische Untersuchungen zur Bedeutung des Uroprophylaktikums Natrium-2-mercaptoethansulfonat (Uromitexan®) für die zytostatische Therapie mit OxazaphosphorinenPublished by S. Karger AG ,1980